Copyright Reports & Markets. All rights reserved.

Global Vaccine Development Service Market Growth (Status and Outlook) 2022-2028

Request for Sample of this report
Buy now

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Vaccine Development Service Market Size 2017-2028
    • 2.1.2 Vaccine Development Service Market Size CAGR by Region 2017 VS 2022 VS 2028
  • 2.2 Vaccine Development Service Segment by Type
    • 2.2.1 Therapeutic
    • 2.2.2 Prophylactic
    • 2.2.3 Other
  • 2.3 Vaccine Development Service Market Size by Type
    • 2.3.1 Vaccine Development Service Market Size CAGR by Type (2017 VS 2022 VS 2028)
    • 2.3.2 Global Vaccine Development Service Market Size Market Share by Type (2017-2022)
  • 2.4 Vaccine Development Service Segment by Application
    • 2.4.1 Enterprise
    • 2.4.2 Government
  • 2.5 Vaccine Development Service Market Size by Application
    • 2.5.1 Vaccine Development Service Market Size CAGR by Application (2017 VS 2022 VS 2028)
    • 2.5.2 Global Vaccine Development Service Market Size Market Share by Application (2017-2022)

3 Vaccine Development Service Market Size by Player

  • 3.1 Vaccine Development Service Market Size Market Share by Players
    • 3.1.1 Global Vaccine Development Service Revenue by Players (2020-2022)
    • 3.1.2 Global Vaccine Development Service Revenue Market Share by Players (2020-2022)
  • 3.2 Global Vaccine Development Service Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Vaccine Development Service by Regions

  • 4.1 Vaccine Development Service Market Size by Regions (2017-2022)
  • 4.2 Americas Vaccine Development Service Market Size Growth (2017-2022)
  • 4.3 APAC Vaccine Development Service Market Size Growth (2017-2022)
  • 4.4 Europe Vaccine Development Service Market Size Growth (2017-2022)
  • 4.5 Middle East & Africa Vaccine Development Service Market Size Growth (2017-2022)

5 Americas

  • 5.1 Americas Vaccine Development Service Market Size by Country (2017-2022)
  • 5.2 Americas Vaccine Development Service Market Size by Type (2017-2022)
  • 5.3 Americas Vaccine Development Service Market Size by Application (2017-2022)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Vaccine Development Service Market Size by Region (2017-2022)
  • 6.2 APAC Vaccine Development Service Market Size by Type (2017-2022)
  • 6.3 APAC Vaccine Development Service Market Size by Application (2017-2022)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Vaccine Development Service by Country (2017-2022)
  • 7.2 Europe Vaccine Development Service Market Size by Type (2017-2022)
  • 7.3 Europe Vaccine Development Service Market Size by Application (2017-2022)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Vaccine Development Service by Region (2017-2022)
  • 8.2 Middle East & Africa Vaccine Development Service Market Size by Type (2017-2022)
  • 8.3 Middle East & Africa Vaccine Development Service Market Size by Application (2017-2022)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Global Vaccine Development Service Market Forecast

  • 10.1 Global Vaccine Development Service Forecast by Regions (2023-2028)
    • 10.1.1 Global Vaccine Development Service Forecast by Regions (2023-2028)
    • 10.1.2 Americas Vaccine Development Service Forecast
    • 10.1.3 APAC Vaccine Development Service Forecast
    • 10.1.4 Europe Vaccine Development Service Forecast
    • 10.1.5 Middle East & Africa Vaccine Development Service Forecast
  • 10.2 Americas Vaccine Development Service Forecast by Country (2023-2028)
    • 10.2.1 United States Vaccine Development Service Market Forecast
    • 10.2.2 Canada Vaccine Development Service Market Forecast
    • 10.2.3 Mexico Vaccine Development Service Market Forecast
    • 10.2.4 Brazil Vaccine Development Service Market Forecast
  • 10.3 APAC Vaccine Development Service Forecast by Region (2023-2028)
    • 10.3.1 China Vaccine Development Service Market Forecast
    • 10.3.2 Japan Vaccine Development Service Market Forecast
    • 10.3.3 Korea Vaccine Development Service Market Forecast
    • 10.3.4 Southeast Asia Vaccine Development Service Market Forecast
    • 10.3.5 India Vaccine Development Service Market Forecast
    • 10.3.6 Australia Vaccine Development Service Market Forecast
  • 10.4 Europe Vaccine Development Service Forecast by Country (2023-2028)
    • 10.4.1 Germany Vaccine Development Service Market Forecast
    • 10.4.2 France Vaccine Development Service Market Forecast
    • 10.4.3 UK Vaccine Development Service Market Forecast
    • 10.4.4 Italy Vaccine Development Service Market Forecast
    • 10.4.5 Russia Vaccine Development Service Market Forecast
  • 10.5 Middle East & Africa Vaccine Development Service Forecast by Region (2023-2028)
    • 10.5.1 Egypt Vaccine Development Service Market Forecast
    • 10.5.2 South Africa Vaccine Development Service Market Forecast
    • 10.5.3 Israel Vaccine Development Service Market Forecast
    • 10.5.4 Turkey Vaccine Development Service Market Forecast
    • 10.5.5 GCC Countries Vaccine Development Service Market Forecast
  • 10.6 Global Vaccine Development Service Forecast by Type (2023-2028)
  • 10.7 Global Vaccine Development Service Forecast by Application (2023-2028)

11 Key Players Analysis

  • 11.1 WuXi AppTec
    • 11.1.1 WuXi AppTec Company Information
    • 11.1.2 WuXi AppTec Vaccine Development Service Product Offered
    • 11.1.3 WuXi AppTec Vaccine Development Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.1.4 WuXi AppTec Main Business Overview
    • 11.1.5 WuXi AppTec Latest Developments
  • 11.2 Charles River Laboratories
    • 11.2.1 Charles River Laboratories Company Information
    • 11.2.2 Charles River Laboratories Vaccine Development Service Product Offered
    • 11.2.3 Charles River Laboratories Vaccine Development Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.2.4 Charles River Laboratories Main Business Overview
    • 11.2.5 Charles River Laboratories Latest Developments
  • 11.3 Creative Biolabs
    • 11.3.1 Creative Biolabs Company Information
    • 11.3.2 Creative Biolabs Vaccine Development Service Product Offered
    • 11.3.3 Creative Biolabs Vaccine Development Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.3.4 Creative Biolabs Main Business Overview
    • 11.3.5 Creative Biolabs Latest Developments
  • 11.4 Creative Biostructure
    • 11.4.1 Creative Biostructure Company Information
    • 11.4.2 Creative Biostructure Vaccine Development Service Product Offered
    • 11.4.3 Creative Biostructure Vaccine Development Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.4.4 Creative Biostructure Main Business Overview
    • 11.4.5 Creative Biostructure Latest Developments
  • 11.5 PPD
    • 11.5.1 PPD Company Information
    • 11.5.2 PPD Vaccine Development Service Product Offered
    • 11.5.3 PPD Vaccine Development Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.5.4 PPD Main Business Overview
    • 11.5.5 PPD Latest Developments
  • 11.6 Merck
    • 11.6.1 Merck Company Information
    • 11.6.2 Merck Vaccine Development Service Product Offered
    • 11.6.3 Merck Vaccine Development Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.6.4 Merck Main Business Overview
    • 11.6.5 Merck Latest Developments
  • 11.7 Sartorius
    • 11.7.1 Sartorius Company Information
    • 11.7.2 Sartorius Vaccine Development Service Product Offered
    • 11.7.3 Sartorius Vaccine Development Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.7.4 Sartorius Main Business Overview
    • 11.7.5 Sartorius Latest Developments
  • 11.8 Eurofins Scientific
    • 11.8.1 Eurofins Scientific Company Information
    • 11.8.2 Eurofins Scientific Vaccine Development Service Product Offered
    • 11.8.3 Eurofins Scientific Vaccine Development Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.8.4 Eurofins Scientific Main Business Overview
    • 11.8.5 Eurofins Scientific Latest Developments
  • 11.9 Statens Serum Institut
    • 11.9.1 Statens Serum Institut Company Information
    • 11.9.2 Statens Serum Institut Vaccine Development Service Product Offered
    • 11.9.3 Statens Serum Institut Vaccine Development Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.9.4 Statens Serum Institut Main Business Overview
    • 11.9.5 Statens Serum Institut Latest Developments
  • 11.10 Thermo Fisher Scientific
    • 11.10.1 Thermo Fisher Scientific Company Information
    • 11.10.2 Thermo Fisher Scientific Vaccine Development Service Product Offered
    • 11.10.3 Thermo Fisher Scientific Vaccine Development Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.10.4 Thermo Fisher Scientific Main Business Overview
    • 11.10.5 Thermo Fisher Scientific Latest Developments
  • 11.11 TRANSVAC
    • 11.11.1 TRANSVAC Company Information
    • 11.11.2 TRANSVAC Vaccine Development Service Product Offered
    • 11.11.3 TRANSVAC Vaccine Development Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.11.4 TRANSVAC Main Business Overview
    • 11.11.5 TRANSVAC Latest Developments
  • 11.12 Azenta US
    • 11.12.1 Azenta US Company Information
    • 11.12.2 Azenta US Vaccine Development Service Product Offered
    • 11.12.3 Azenta US Vaccine Development Service Revenue, Gross Margin and Market Share (2020-2022)
    • 11.12.4 Azenta US Main Business Overview
    • 11.12.5 Azenta US Latest Developments

12 Research Findings and Conclusion

The global market for Vaccine Development Service is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC Vaccine Development Service market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States Vaccine Development Service market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe Vaccine Development Service market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China Vaccine Development Service market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key Vaccine Development Service players cover WuXi AppTec, Charles River Laboratories, Creative Biolabs, Creative Biostructure and PPD, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage
This latest report provides a deep insight into the global Vaccine Development Service market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global Vaccine Development Service market, with both quantitative and qualitative data, to help readers understand how the Vaccine Development Service market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.

Market Segmentation:
The study segments the Vaccine Development Service market and forecasts the market size by Type (Therapeutic, Prophylactic and Other), by Application (Enterprise and Government.), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
Therapeutic
Prophylactic
Other

Segmentation by application
Enterprise
Government

Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Major companies covered
WuXi AppTec
Charles River Laboratories
Creative Biolabs
Creative Biostructure
PPD
Merck
Sartorius
Eurofins Scientific
Statens Serum Institut
Thermo Fisher Scientific
TRANSVAC
Azenta US

Chapter Introduction
Chapter 1: Scope of Vaccine Development Service, Research Methodology, etc.
Chapter 2: Executive Summary, global Vaccine Development Service market size and CAGR, Vaccine Development Service market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Vaccine Development Service revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Vaccine Development Service revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Vaccine Development Service market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including WuXi AppTec, Charles River Laboratories, Creative Biolabs, Creative Biostructure, PPD, Merck, Sartorius, Eurofins Scientific and Statens Serum Institut, etc.
Chapter 14: Research Findings and Conclusion

Buy now